ENTRY       D09662                      Drug
NAME        Rontalizumab (USAN/INN)
FORMULA     C6486H9990N1722O2026S44
EXACT_MASS  145825.9336
MOL_WEIGHT  145915.9026
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCATSGYTFT EYIIHWVRQA PGKGLEWVAS INPDYDITNY
            NQRFKGRFTI SLDKSKRTAY LQMNSLRAED TAVYYCASWI SDFFDYWGQG TLVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELLGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSREEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQSVS TSSYSYMHWY QQKPGKAPKV LISYASNLES
            GVPSRFSGSG SGTDFTLTIS SLQPEDFATY YCQHSWGIPR TFGQGTKVEI KRTVAAPSVF
            IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (Disulfide bridge: H22-H96, H144-H200, H261-H321, H367-H425, H226-H'226, H229-H'229, L23-L92, L138-L198, H220-L218)
  TYPE      Peptide
EFFICACY    Immunosuppressant, Anti-IFN-alpha antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of systemic lupus erythematosus (SLE)
TARGET      IFNA [HSA:3439 3440 3441 3442 3443 3444 3445 3446 3447 3448 3449 3451 3452] [KO:K05414]
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interferons
                IFNA
                 D09662  Rontalizumab (USAN/INN)
DBLINKS     CAS: 948570-30-7
            PubChem: 124490402
///
